E. Jablonkai et al. / Tetrahedron Letters 54 (2013) 5873–5875
5875
Table 2
Selected spectral data for phosphinates 4, 6, and 8
½M þ Hꢀþfound
½M þ Hꢀþrequires
d2Pb
Product
31P NMR (121.5 MHz, CDCl3)
4
6
68.5
79.4 (broad)
68.6
203.1203
191.1204
203.1201
191.1201
79.40 (50%)
79.38 (50%)
72.5 (60%)
78.4 (20%)
79.0 (20%)
8A
8B1
8B2
72.4 (92%)
78.3 (7%)
79.9 (5%)
205.1350
205.1357
1-Isobutoxy-3-methyl-3-phospholene 1-oxide (2f): 31P NMR and HRMS: Table 1;
13C NMR (75.5 MHz, CDCl3) d 18.8 (2 ꢂ CHCH3), 20.9 (d, J = 12.9, C3–CH3), 29.3
(d, J = 6.2, OCH2CH), 30.8 (d, J = 88.3, C2), 33.5 (d, J = 92.3, C5), 70.8 (d, J = 7.0,
OCH2), 120.4 (d, J = 10.8, C3), 136.4 (d, J = 16.9, C4); 1H NMR (300 MHz, CDCl3) d
0.95 (d, 6H, J = 6.7, CHCH3), 1.80 (s, 3H, C3–CH3), 1.86–2.03 (m, 1H, OCH2CH),
2.28–2.55 (m, 4H, 2 ꢂ PCH2), 3.79 (t, 2H, J = 6.7, OCH2), 5.53 (d, 1H, J = 35.9,
C4–H).
In summary, a mild and efficient esterification of a series of five-
membered cyclic phosphinic acids was elaborated utilizing the
T3PÒ reagent.
Acknowledgment
1-(1-Methylpropoxy)-3-methyl-3-phospholene 1-oxide (2g): 31P NMR and HRMS:
Table 1; 13C NMR (75.5 MHz, CDCl3) d 9.5 (CH2CH3), 20.6 (d, J = 12.9, C3–CH3),
21.6 (OCHCH3), 30.6 (d, J = 5.0, OCHCH2), 31.3 (d, J = 88.6, C2, isomer A), 31.7 (d,
J = 88.6, C2, isomer B), 34.0 (d, J = 92.5, C5, isomer A), 34.4 (d, J = 92.5, C5,
isomer B), 74.3 (d, J = 6.9, OCH), 120.1 (d, J = 11.1, C3, isomer A), 120.3 (d,
J = 11.0, C3, isomer B), 136.1 (d, J = 16.9, C4, isomer A), 136.2 (d, J = 16.8, C4,
isomer B); 1H NMR (300 MHz, CDCl3) d 0.87 (t, 3H, J = 7.4, CH2CH3), 1.27 (d, 3H,
J = 6.2, OCHCH3), 1.42–1.71 (m, 2H, OCHCH2), 1.73 (s, 3H, C3–CH3), 2.15–2.50
(m, 4H, 2 ꢂ PCH2), 4.32–4.53 (m, 1H, OCH), 5.46 (d, 1H, J = 35.8, C4–H).
1-(1-Ethylpropoxy)-3-methyl-3-phospholene 1-oxide (2j): 31P NMR and HRMS:
Table 1; 13C NMR (75.5 MHz, CDCl3) d 9.5 (CH2CH3), 20.9 (d, J = 12.9, C3–CH3),
28.0 (d, J = 3.6, OCHCH2), 31.8 (d, J = 88.8, C2), 34.5 (d, J = 92.6, C5), 79.4 (d,
J = 7.4, OCH), 120.5 (d, J = 10.9, C3), 136.4 (d, J = 16.9, C4); 1H NMR (300 MHz,
CDCl3) d 0.94 (t, 6H, J = 7.4, CH2CH3), 1.51–1.71 (m, 4H, 2 ꢂ OCHCH2), 1.80 (s,
3H, C3–CH3), 2.28–2.59 (m, 4H, 2 ꢂ PCH2), 4.25–4.41 (m, 1H, OCH), 5.53 (d, 1H,
J = 35.7, C4–H).
This project was supported by the Hungarian Scientific and Re-
search Fund (OTKA K83118).
References and notes
}
1-Cyclohexyloxy-3-methyl-3-phospholene 1-oxide (2k): 31P NMR and HRMS:
Table 1; 13C NMR (75.5 MHz, CDCl3) d 20.6 (d, J = 13.0, C3–CH3), 23.6 (C30), 24.9
(C40), 31.6 (d, J = 88.5, C2), 33.79 and 33.83 (d, J = 2.9, C20), 34.3 (d, J = 92.5, C5),
74.6 (d, J = 6.8, C10), 120.2 (d, J = 11.0, C3), 136.1 (d, J = 16.9, C4); 1H NMR
(300 MHz, CDCl3) d 1.01–1.94 (m, 13H, C3–CH3, 5 ꢂ CH2), 2.18–2.52 (m, 4H,
2 ꢂ PCH2), 4.20–4.40 (m, 1H, C10–H), 5.44 (1H, J = 35.9, C4–H).
8. (a) Wissmann, H.; König, W.; Teetz, V.; Geiger, R. 16th Peptides Processing
1-(2-Phenylethoxy)-3-methyl-3-phospholene 1-oxide (2m): 31P NMR and HRMS:
Table 1; 13C NMR (75.5 MHz, CDCl3) d 20.8 (d, J = 12.9, C3–CH3), 30.8 (d,
J = 88.1, C2), 33.4 (d, J = 91.8, C5), 37.2 (d, J = 5.8, OCH2CH2), 65.4 (d, J = 6.8,
OCH2), 120.3 (d, J = 10.9, C3), 126.7 (C40), 128.6 (C20), 129.1 (C30), 136.3 (d,
J = 17.0, C4), 137.5 (C10); 1H NMR (300 MHz, CDCl3) d 1.73 (s, 3H, C3–CH3),
2.00–2.60 (m, 4H, 2 ꢂ PCH2), 2.99 (t, 2H, J = 6.6, OCH2CH2), 4.12–4.33 (m, 2H,
OCH2), 5.46 (1H, J = 36.0, C4–H), 7.12–7.40 (m, 5H, ArH).
10. General procedure for the esterification of phosphinic acids in the presence of T3PÒ: a
mixture of 0.76 mmol of phosphinic acid (1-hydroxy-3-methyl-3-phospholene
1-oxide: 0.10 g, 1-hydroxy-3,4-dimethyl-3-phospholene 1-oxide: 0.11 g,
1-hydroxy-3-methyl-phospholane 1-oxide: 0.10 g, 1-hydroxy-3,4-dimethyl-
phospholane 1-oxide: 0.11 g) and 0.55 mL (50 wt %, 0.84 mmol) of T3PÒ in
EtOAc was stirred for 10 min. To the resulting mixture was added 2.3 mmol (or,
in the case of non-volatile reagents, 1.1 mmol) of the alcohol [methanol:
0.09 mL, ethanol: 0.13 mL, propanol: 0.17 mL, isopropanol: 0.18 mL, butanol:
0.21 mL, isobutanol: 0.21 mL, sec-butanol: 0.21 mL, pentanol: 0.25 mL,
isopentanol: 0.25 mL, 3-pentyl alcohol: 0.25 mL, cyclohexanol: 0.12 mL,
benzyl alcohol: 0.12 mL, 2-phenylethanol: 0.14 mL, 2-(1-naphthyl)ethanol:
0.20 g or (1R,2S,5R)-(ꢁ)-menthol: 0.18 g] and the contents of the flask were
stirred at 25 °C for the appropriate amount of time. The excess T3P reagent was
hydrolyzed with 7 mL of 10% NaHCO3 solution and the aqueous phase was
extracted with EtOAc (2 ꢂ 15 mL). The combined organic phase was dried
(Na2SO4), filtered, and evaporated to provide a crude residue that was passed
through a thin (ca. 3–4 cm) layer of silica gel using 3% MeOH in CH2Cl2 as the
eluent to give the products (2a–p, and 4, 6, and 8) in P99% purity, as oils.
1-[2-(1-Naphthyl)ethoxy]-3-methyl-3-phospholene 1-oxide (2n): 31P NMR and
HRMS: Table 1; 13C NMR (75.5 MHz, CDCl3) d 20.8 (d, J = 12.9, C3–CH3), 30.8 (d,
J = 87.9, C2), 33.5 (d, J = 91.9, C5), 34.4 (d, J = 5.6, OCH2CH2), 65.0 (d, J = 6.8,
OCH2), 120.3 (d, J = 10.9, C3), 123.7 (C20)a, 125.6 (C30)a, 125.8 (C10)a, 126.3
(C40)a, 127.3 (C90)a, 127.6 (C80)b, 128.9 (C100)b, 132.1 (C70)b, 133.5 (C60)b, 134.0
(C50)b, 136.3 (d, J = 16.9, C4),a,b may be reversed; 1H NMR (300 MHz, CDCl3) d
1.67 (s, 3H, C3–CH3), 2.01–2.45 (m, 4H, 2 ꢂ PCH2), 3.47 (t, 2H, J = 7.0,
OCH2CH2), 4.35 (q, 2H, J = 7.2, OCH2), 5.37 (1H, J = 35.4, C4–H), 7.26–7.56 (m,
4H, ArH), 7.74 (d, 1H, J = 7.6, C50–H)c, 7.84 (d, 1H, J = 7.7, C40–H)c; 8.04 (d, 1H,
J = 8.1, C80–H)c, cmay be reversed.
Spectral data for the additional products (4, 6 and 8) are listed in Table 2.